Type 2 diabetes mellitus Trials in Palm Harbor, United States
Conditions / Type 2 diabetes mellitus / Palm Harbor, United States
Type 2 diabetes mellitus is a medical condition with active clinical research programs worldwide.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01676220 | Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy | COMPLETED | PHASE3 |
| NCT01864174 | Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes | COMPLETED | PHASE4 |
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | TERMINATED | PHASE3 |
| NCT02320721 | Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications | COMPLETED | PHASE3 |
| NCT00242372 | GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin | TERMINATED | PHASE3 |
| NCT01499095 | Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy | COMPLETED | PHASE3 |
| NCT02973321 | A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 |
| NCT01789957 | Extension Study for 2993-112 | COMPLETED | PHASE3 |
| NCT01499082 | Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin | COMPLETED | PHASE3 |
| NCT00642616 | Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease | TERMINATED | PHASE3 |